Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,567.20
(
1.22%
)
Dow Jones
46,208.47
(
1.38%
)
Brent Oil
99.73
(
3.04%
)
Bitcoin
70,596.00
(
-0.43%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

vinmantoo

Send PM Follow Ignore
Followers 28
Posts 4683
Boards Moderated 0
Alias Born 07/25/2007

vinmantoo

Re: croumagnon post# 6807

Wednesday, 01/09/2008 12:34:40 AM

Wednesday, January 09, 2008 12:34:40 AM

Post# of 19309
GTCB is trying to show non-inferiority of rATIII to plasma derived ATIII. What we need to know is what percentage of HD patients given plasma derived ATIII had a symptomatic DVT. From the European trial of rATIII, we already know that zero patients out of 14 HD patients had a symptomatic DVT.

Vinny

P.S. Jesse, you are right on the money with the stupidity of having to conduct European and US trials of the same drug. What a waste!
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today